FDA Drug Application (091001) for NISOLDIPINE by MYLAN

Back to FDA Applications sponsored by MYLAN

Application Number091001
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage8.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNISOLDIPINE
Active IngredientNISOLDIPINE

Active IngredientCount
List of drugs with Active Ingredient NISOLDIPINE2


Back to FDA Applications sponsored by MYLAN